Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Imagenet has acquired Analytica Consulting, adding data engineering, analytics, AI, visualization, and governance capabilities to its healthcare operations services. The transaction closed on August 21, 2026, and financial terms were not disclosed.
Monod Bio and SignalChem Biotech signed a nonexclusive license for LuxSit luciferase technology and NovoBodies for custom luminescent assays and protein fusion services.
PENTAX Medical has expanded its partnership with Magentiq Eye Ltd. to bring MAGENTIQ-COLO to more endoscopy markets through PENTAX Medical video processors.
PrecisionLife has selected Gencove as its US consumer genetics platform partner for DNA wellness reports, starting with a Post COVID report for general wellness and education.
Arintra raised $25 million in Series B funding led by Define Ventures, bringing its total funding to $51 million. The company plans to expand its AI platform for healthcare revenue assurance across more health systems and revenue cycle functions.
Onos Health raised $17 million in Series A funding led by Costanoa Ventures, with participation from Flare Capital Partners and CVS Health Ventures. The company provides an AI platform for behavioral health clinical intelligence used by health plans.
Knack has launched an MCP Server that connects AI coding tools to a relational database backend with HIPAA compliant options, access controls, workflows, automations, integrations, and managed hosting.
Researchers at Stowers Institute for Medical Research developed PISA, a method that shows how genomic AI models connect DNA bases to predictions. The method can separate technical bias from biological signals and helped identify DNA sequences tied to nucleosome positioning and 3D chromatin domain boundaries.
Spineart and eCential Robotics received FDA 510(k) clearance for the PERLA TL application for use with the eCential Op.n navigation and robotics platform.
HTA and NXTUS selected seven startups for the first HealthCatalyst Northwest Arkansas pilot cohort, with each company paired with a local community partner for a $20,000 project.
Annie has launched a Digital Coworker for dental teams that expands its AI receptionist into insurance verification, recare, appointment confirmation, and cancellation management.
PartsSource received a strategic investment from Memorial Hermann Health System for its clinical technology management platform, which supports parts, service, contracts, asset intelligence, and workforce capacity for hospitals.
ECRI has expanded its Problem Reporting Network to collect reports of errors, malfunctions, near misses, and unsafe behavior involving AI tools and AI enabled devices used in patient care.
Biogen has selected Veeva Vault CRM as its commercial platform. The Veeva suite includes Agent Call Reporting to generate commercial evidence for AI based commercial workflows.
BreakBio says it will enter the clinic next quarter with personalized cancer drugs that use AI analysis of tumor sequencing and mass spectrometry data to identify patient targets.
Regeneron Pharmaceuticals has committed to Veeva Vault CRM globally, with plans to use AI powered field engagement to generate Commercial Evidence for commercial teams.
FDB has deployed FDB Script Agent with Tebra, adding AI generated prescription drafting to Tebra AI Note Assist for clinician review.
DeepCura introduced the Electronic Health Workforce, a clinician supervised AI system for reception, scribing, intake, scheduling, and inbox work in healthcare practices.
Brightn and OpenLoop have partnered to let Brightn users schedule licensed therapy sessions through the Brightn app. The service connects daily mental wellness tools with OpenLoop's national therapist network.
NVOX has launched NVOX Network, a US clinical network for ADHD assessment that lets qualified clinicians use its platform with their own clients or review cases through NVOX Direct.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
